HOFSETH BIOCARE ASHOFSETH BIOCARE ASHOFSETH BIOCARE AS

HOFSETH BIOCARE AS

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪849.42 M‬NOK
−0.24NOK
‪−106.68 M‬NOK
‪190.82 M‬NOK
‪180.21 M‬
Beta (1Y)
0.36

About HOFSETH BIOCARE AS

Headquarters
Ålesund
Employees (FY)
65
Founded
2009
ISIN
NO0010598683
FIGI
BBG0029P0143
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. Its products include ProGo Bioactive Peptides, OmeGo Salmon Oil, CalGo Calcium Collagen Complex, and Shop Branded Products. The company was founded by Roger Hofseth in 2000 and is headquartered in Alesund, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HBC is 2.10 NOK — it has decreased by 2.33% in the past 24 hours. Watch HOFSETH BIOCARE AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange HOFSETH BIOCARE AS stocks are traded under the ticker HBC.
HBC stock has risen by 3.45% compared to the previous week, the month change is a 1.41% fall, over the last year HOFSETH BIOCARE AS has showed a 34.17% decrease.
HBC reached its all-time high on Nov 27, 2019 with the price of 10.91 NOK, and its all-time low was 1.12 NOK and was reached on Oct 4, 2017. View more price dynamics on HBC chart.
See other stocks reaching their highest and lowest prices.
HBC stock is 4.88% volatile and has beta coefficient of 0.36. Track HOFSETH BIOCARE AS stock price on the chart and check out the list of the most volatile stocks — is HOFSETH BIOCARE AS there?
Today HOFSETH BIOCARE AS has the market capitalization of ‪849.42 M‬, it has increased by 3.45% over the last week.
Yes, you can track HOFSETH BIOCARE AS financials in yearly and quarterly reports right on TradingView.
HOFSETH BIOCARE AS is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
HBC net income for the last quarter is ‪−29.01 M‬ NOK, while the quarter before that showed ‪−51.89 M‬ NOK of net income which accounts for 44.10% change. Track more HOFSETH BIOCARE AS financial stats to get the full picture.
No, HBC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 28, 2024, the company has 65.00 employees. See our rating of the largest employees — is HOFSETH BIOCARE AS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOFSETH BIOCARE AS EBITDA is ‪−79.72 M‬ NOK, and current EBITDA margin is −52.39%. See more stats in HOFSETH BIOCARE AS financial statements.
Like other stocks, HBC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOFSETH BIOCARE AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOFSETH BIOCARE AS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOFSETH BIOCARE AS stock shows the sell signal. See more of HOFSETH BIOCARE AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.